Beam Therapeutics Reports Third Quarter 2024 Financial Results and Progress Across Priority Programs
Provided By GlobeNewswire
Last update: Nov 5, 2024
Initial Clinical Data for BEAM-101 and Preclinical Non-human Primate Data for ESCAPE Accepted for Presentation at American Society of Hematology (ASH) Annual Meeting
Read more at globenewswire.com
